UnitedHealth Group's UNH stock price pulled back following the Q3 earnings release in what can best be described as a temper tantrum. The results weren't bad, outpacing the consensus estimates and compounded by solid guidance, but the market wanted more, so it sold off.  The takeaway is that this healthy, dividend-paying growth machine is executing despite the headwinds and delivering value for investors; the post-release dip is a buying opportunity. Value building is expected to continue in Q4 and next yea ...